✦ LIBER ✦

DUAL ANTIPLATELET THERAPY OR APIXABAN IN PATIENTS INELIGIBLE FOR VITAMIN-K ANTAGONISTS FOR STROKE PREVENTION IN ATRIAL FIBRILLATION: LESSONS FROM THE RECENT ASPIRIN-CONTROLLED TRIALS

✍ Scribed by Jeroen Jaspers Focks; Marc A. Brouwer; Freek W.A. Verheugt

Book ID: 118580873
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 193 KB
Volume: 57
Category: Article
ISSN: 1558-3597
DOI: 10.1016/s0735-1097(11)60061-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bleeding During Treatment With Aspirin V

Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin: The Apixaban Versus Acetylsalicylic Acid to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin k Antagonist Treatment (AVERROES) Trial

✍ Flaker, G. C.; Eikelboom, J. W.; Shestakovska, O.; Connolly, S. J.; Kaatz, S.; B 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 850 KB

Oral direct thrombin inhibitor AZD0837 f

Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: A Phase II study of AZD0837 in patients who are appropriate for but unable or unwilling to take vitamin K antagonist therapy

✍ Gregory Y.H. Lip; Lars H. Rasmussen; S. Bertil Olsson; Sofia Zetterstrand; Chris 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 659 KB